Lightning Round: Teva Pharma, Equinix, Verizon and More

Discovery Communications : DISCA is a buy, Cramer said.

Teva Pharmaceutical : Investors fears of generic competition for Teva’s multiple sclerosis drug have made this stock hard to own, Cramer said. So while he likes the company, the best he can say about it right now is “don’t buy.”

Equinix : Cramer has some doubts about the data-center business, so he recommended taking profits in EQIX.

Verizon : Cramer is bullish on VZ.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com